I was away reporting most of today, and while I was out, a few federal emails landed in my mail with what probably sounded like a thud. One was an official announcement from the Food and Drug Administration; the others were copies of FDA and NIH emails that people there thought I should see.
They all said the same thing: The six vials of smallpox virus found in an FDA cold-storage room on the National Institutes of Health campus July 1 and announced by the CDC last week had company. A lot of company: 321 other vials. Some of them contained other "select agents," infectious pathogens considered serious enough -- for the illness they create, or the lack of a vaccine to prevent or drugs to treat them -- to be considered potential bioterror agents.
(If you've missed this story so far, catch up here, here, here and here.)
Here's the gist of the FDA's external announcement:
The rest of the announcement confirms what my reporting uncovered last week: The room where the vials were found, though now belonging to the FDA, was once the property of NIH's Division of Biological Standards, which worked on the reliability of vaccines:
The internal NIH announcement, signed by director Dr. Francis Collins, goes into detail about what comes next:
Much more to come, no doubt.
Meanwhile, as I mentioned this morning, leadership from the Centers for Disease Control and Prevention were in front of Congress today to explain the other two infectious-organism misfires that are happening coincident to this: the errors in the CDC's anthrax and influenza labs. Here is the video of the full session (2 hours, 40 minutes) in the House of Representatives. I haven't had the chance to watch it yet; I'll just leave it here for you: